Argenx Se ARGX Stock Price, News & Info The Motley Fool

Argenx developed and is commercializing the neonatal Fc receptor blocker in the U.S., Japan, and the EU. Its product pipeline includes product candidates such as ARGX-117, ARGX-118, ARGX-115, ARGX-116, and others. 18 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for argenx in the last year. There are currently 1 hold rating and 17 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” ARGX shares. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors.

Historical and current end-of-day data provided by FACTSET. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Latest ARGX News From Around the Web

A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation. Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score.

• The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock.
• There are currently 1 hold rating and 17 buy ratings for the stock.
• Shares traded up through resistance Monday morning on good volume, but the move was ultimately held back by a nasty overall market.
• The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
• This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 .

The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype. 52 week low is the lowest price of a stock in the past 52 weeks, or one year. Argen X SE – ADR 52 week low is $267.35 as of April 29, 2023. 52 week high is the highest price of a stock in the past 52 weeks, or one year.

Argenx Se Company Info

Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies. High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks.

This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.27% per year. These returns cover a period from January 1, 1988 through April 3, 2023.

This is a higher https://1investing.in/ sentiment than the 0.65 average news sentiment score of Medical companies. The company’s average rating score is 2.94, and is based on 17 buy ratings, 1 hold rating, and no sell ratings. Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Inflation & Prices

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. We’d like to share more about how we work and what drives our day-to-day business. CompareARGX’s historical performanceagainst its industry peers and the overall market.

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.

In terms of volatility of its share price, ARGX is more volatile than merely 0.5% of stocks we’re observing. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Maintaining independence and editorial freedom is essential to our mission of empowering investor success.

Analysts Offer Insights on Healthcare Companies: ImmunoGen (IMGN), Argenx Se (ARGX) and Kymera Therapeutics (KYMR)

According to 13 analysts, the average rating for ARGX stock is “Strong Buy.” The 12-month stock price forecast is $452.85, which is an increase of 16.75% from the latest price. According to analysts’ consensus price target of $452.94, argenx has a forecasted upside of 16.8% from its current price of $387.88. Argenx has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

• ARGX scores best on the Sentiment dimension, with a Sentiment rank ahead of 96.96% of US stocks.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries.
• One share of ARGX stock can currently be purchased for approximately $387.88.
• As an investor, you want to buy stocks with the highest probability of success.

$ARGX with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $ARGX after a Positive Under reaction following its earnings release placing the stock in drift D. The PEAD projected a Bearish outlook for $ARGX after a Positive Under reaction following its earnings release placing the stock in drift D. Other market data may be delayed by 15 minutes or more. VYVGART is the first neonatal Fc receptor blocker approved in the UK for the treatment of adults living with generalized myasthenia gravis who are anti-acetylcholine receptor anti… P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Earnings for argenx are expected to grow in the coming year, from ($8.77) to ($4.78) per share.

Short interest in argenx has recently increased by 1.65%, indicating that investor sentiment is decreasing.

Argenx does not have a long track record of dividend growth. There may be delays, omissions, or inaccuracies in the Information. The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%.

An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world. Argenex SE might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 . © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Style is calculated by combining value and growth scores, which are first individually calculated. Morningstar Quantitative ratings for equities are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Breakout trade in ARGXArgenx is another biotech stock setting up in a textbook breakout pattern. Shares traded up through resistance Monday morning on good volume, but the move was ultimately held back by a nasty overall market. ARGX still held up well, and will likely continue its advance higher. Argenx is another biotech stock setting up in a textbook breakout pattern.

Fundamentally, the driving catalyst for biotech stocks to buy centers on the possibility of supporting paradigm-shifting medical breakthroughs. For example, a report published by the JAMA Network indi… Raised $65 million in an IPO on Thursday, May 18th 2017. The company issued 3,600,000 shares at a price of $18.18 per share. Cowen and Company and Piper Jaffray acted as the underwriters for the IPO and JMP Securities and Wedbush PacGrow were co-managers. Sign-up to receive the latest news and ratings for argenx and its competitors with MarketBeat’s FREE daily newsletter.

These are established companies that reliably pay dividends. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding.

Provide specific should you buy a high deductible health insurance and services to you, such as portfolio management or data aggregation. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Argenx is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.

Argenx SE operates as a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. It operates from the Netherlands, Belgium, the United States of America, Japan, Switzerland, Germany and France. It evaluates efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. De Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Breda, the Netherlands. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. The group has partnered with academic researchers through its Immunology Innovation Program and aims to translate immunology breakthroughs into a portfolio of novel antibody-based medicines.